James
The debate concerning the treatment of addiction in America is at least two centuries old, and the point is that we continue to argue. However, our management of it has become so radically different that the early professionals could not identify it the same as it is now. Benjamin Rush, who created a pamphlet in 1784 arguing that alcoholism was a disease, not a moral weakening, is the earliest American to drive the same point, happening to be a signer of the Declaration of Independence. It was another century and half before the medical fraternity listened to him. Here is the slobby, unexpected account of how we began to see addiction problems as a Punishable Sin and now we are seeing them as a disorder in brain functioning, and suddenly that leaves you when you are trying to figure out how to get the treatment that will best address your situation.
Why Early America Saw Addiction as a Crime, Not a Condition
The 1800s dealt with excessive drinking like we might deal with, say, the stop sign. It was a disability that needed to be cured, rather than taken care of. The national temperance movement spread the spirit of religious zealots and by 1920, alteration of the 18th Amendment outlawed alcohol. Obviously, Prohibition was not effective. It induced a feeding frenzy on the black market and, in fact, made drinking more cool to the youths. Sound familiar?
By 1933 with the repeal of Prohibition, it had to acknowledge that not permitting substances wholesale was not a policy, it was only a declaration of morality. However, with such a confession, treatment facilities were not developed. Alcoholics continued to be incarcerated, sent to insane hospitals or left to deal with it on their own. Akron, Ohio, was the first to come up with the first actual movement towards medical treatment, in the unlikely figure of a group of recovering alcoholics who in 1935 formed Alcoholics Anonymous. Theirs was a social and spiritual and not a medical model which had worked on thousands of people who had been failing everywhere else. Up to now, 12-step facilitate is one of the most predominant methods of treatment at American treatment centers.
The Food and Drug Administration Steps In
Genuinely new to addiction care was the idea of the first point of contact being with a physician rather than a judge or a minister, which came into existence in the mid-20 th century. It was the American Medical Association that made the official classification of alcoholism a disease in 1956 and the drug addiction in 1965 by the American Psychiatric Association. These categories were important in that they changed insurance coverage discourses and research funding agendas. Hospitals could not refuse a person in withdrawal anymore, as they had been used to rejecting them over decades, once addiction became a medical diagnosis.
The federal government was still decades lagging behind the medical community however. This would change in 1970 when President Nixon signed the Comprehensive Drug Abuse Prevention and Control Act. Developed into the legislation that was buried was the formation of the National Institute on Drug Abuse, which initiated the serious scientific studies of the effect of the substance with the brain. An amendment made in 1972 on the social security act created the first federal flow of resources towards the programs of drug abuse treatment. The nation managed to achieve in a span of five years what originally was the lack of any formal treatment system other than community clinics in each of the states. The Social Security Act was given a broad remit, which is recorded in the National Archives being used to establish the foundation of the modern treatment structure almost silently by new amendments to the original act.
How the War on Drugs Slowed Everything Down
The politics changed, just like treatment took its stride. In 1971 Nixon started the War on Drugs and in the 1980s Ronald Reagan put it on a tremendous scale. The message was clear there was a criminal justice concern of addiction and the remedy was prison, not rehabilitation. The 1980s showed a proportional increase in federal expenditure on law enforcement and incarceration of treatment of about ten to one. The consequence was a prison population explosion, especially of Black and Latino communities, although real presence of substance use disorders remained unchanged.
The irony here is that criminalization moved treatment further out the mainstream at a time when science was increasingly improving. Methadone maintenance of opioid addiction had been developed in 1970s by researchers at Yale and Rockefeller University. It was successful as it slipped the number of overdose deaths and crime among participants tremendously. However, it was lent some suspicion since it was linked to addiction itself by the lawmakers. It would be until the 1990s that Medicaid began covering methadone in most of the states. That is why we were busy constructing more and more prisons whilst we had a medical solution in clinics ready that had been twenty years old.
What the AIDS Crisis Actually Changed
HIV epidemic was triggering a reckoning of the public health which the politics alone could never. In 1980s, the officials were required to decide between safeguarding the health of the population and prosecuting the drug use since injection drug users had become some of the most at risk populations in terms of transmission of HIV. They picked up public health, grudgingly. In the 1990s needle exchange programs began to emerge and harm reduction was the first term to enter American English. It was an easy, albeit hot-tempered concept: go to them at the place where they are, minimize the harm of the drug use even in case they are not prepared to quit, and keep them alive until they can get treatment in the future.
This period also produced the first large-scale research on what actually worked in treatment settings. A landmark 1997 study published in the New England Journal of Medicine examined methadone maintenance outcomes across multiple clinics, finding that higher doses and longer retention correlated with dramatically better outcomes, including reduced heroin use and fewer HIV risk behaviors. That study pushed the medical establishment to treat opioid addiction like a chronic condition requiring ongoing management, not a short-term detox that could be cured in thirty days. The shift was slow, but it fundamentally changed how physicians thought about relapse, which had previously been treated as a personal failure rather than a feature of chronic disease.
The Modern Era and the Opioid Crisis
Then there was OxyContin, and things were once more. The drug, which was marketed aggressively with minimal mention of its potential to cause addiction, was launched by Purdue Pharma in 1996 and the number of prescriptions increased exponentially. In 2010, opioid use disorder had resulted in a generation of individuals with heroin never having used opioid due to prescription opioid misuse. With accompanying stricter rules regarding prescriptions, most people just turned to street opioids. The number of victims was astounding: in late 2020 to late 2021 alone, CDC documented over 100,000 overdose deaths in the United States, the highest annual past total ever recorded.
The modern crisis finally made its way to the science behind the public health response. The standard of care rather than an afterthought became medication-assisted treatment, with the use of buprenorphine or methadone. The SUPPORT Act of 2018 not only increased the access to these medicines but also financed the treatment in rural communities. States started to require the insurers to provide addiction services at the same parity as physical health care. The Substance Abuse and Mental Health Services Administration monitor the situation in treatment nationally, and their statistics reveal that the number of treatment facilities providing medication-assisted treatment increased more than twofold in 2010-2020. That’s good progress, but it is progress that has decades of scientific underpinning finally coming up to policy.
Where Treatment Stands Now
The present situation in the treatment sphere is a quilt, which is not inherently a bad quality. You have time-tested 30 day inpatient programs that have originated since the 1950s Minnesota Model. You have medication-assisted treatment which has emerged off of the 1970s methadone clinics. You have injuries reduction services which resulted out of the AIDS crisis. And you have more advanced virtual treatment programs that were not in ten years ago. Each model focuses on a distinct area of the puzzle, and a combination of multiple approaches is also often the best treatment plans.
When you are making decisions or you are choosing, and you are thinking about one or two other people you are concerned about, the selection of choices can be daunting. You may also hear about intensive outpatient (maintaining your employment and attending daily therapy) and partial hospitalization (closer to inpatient) and sober living (offering structure but not clinical oversight). The positive thing is that the discipline has ceased its pretenses that a single approach suits all. Programs from greaterbostonaddictioncenters.com/drug-rehab-and-addiction-treatment-programs/iop-program-boston and similar facilities now offer tiered care that adjusts to each person’s needs rather than forcing everyone through the same template.
The Next Frontier in Addiction Treatment
Now we have an opportunity to observe the field shift to individualized medicine. Genetic testing is able to determine individuals with poor metabolism of certain medications which will enable doctors to decide on the choice between buprenorphine and naltrexone through evidence rather than speculation. The question that a number of researchers are investigating is whether psychedelic-assisted therapy, especially using psilocybin or ibogaine can disrupt addiction patterns in a manner that conventional treatments cannot do. The evidence is encouraging but preliminary, and there are a few trials that demonstrate long-term abstinence rates exceeding sixty percent at twelve months.
The other major transformation is a de-stigmatization of relapse as such. Through American history, practically the only correct way of relapsing was that you had fallen short and had to start anew. The contemporary opinion is based on the chronic disease model which was introduced by Benjamin Rush as early as 1784 where relapse is seen as natural in a recovery process which should be adjusted to, but not to be shameful. The reopening of that reframing has given way to re-engagement strategies to be able to get people back into treatment at the earliest opportunity of slip and not necessarily have to wait until another crisis strikes.
It has been two centuries and millions of lives to get to the point where the arc of American addiction treatment is arching towards medical care and away towards moral judgment. The following chapter hinges on the possibility of maintaining the benefits of the sciences and creating a system that will be made available to everybody who needs it.
Here then is something to think of, two centuries of history, and how do you come to find care now? Find programs providing various degrees of care, applying evidence-based therapies, and seeing addiction as a condition that is a medical addition and reacts to the appropriate treatment. The equipment could not be superior. Whether the policy level and the personal level of will to use them has not finally caught up, is the question.
